Home
Scholarly Works
Intrathecal scAAV9 Gene Therapy Is an Effective...
Conference

Intrathecal scAAV9 Gene Therapy Is an Effective Treatment for PPT1-Deficiency in the Preclinical INCL Mouse Model

Authors

Rozenberg AJ; Lykken EA; Gray SJ

Volume

25

Pagination

pp. 248-248

Publisher

CELL PRESS

Publication Date

May 1, 2017

Name of conference

20th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Conference place

DC, Washington

Conference start date

May 10, 2017

Conference end date

May 13, 2017

Conference proceedings

MOLECULAR THERAPY

Issue

5

ISSN

1525-0016

Contact the Experts team